caprylates has been researched along with Cardiac Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, L; Han, Y; Jiang, Q; Lv, N; Wang, C; Zhao, M; Zhong, W | 1 |
| Barbee, RW; Burns, AH; Shepherd, RE | 1 |
2 other study(ies) available for caprylates and Cardiac Diseases
| Article | Year |
|---|---|
The roles of bone morphogenetic protein 2 in perfluorooctanoic acid induced developmental cardiotoxicity and l-carnitine mediated protection.
Topics: Animals; Bone Morphogenetic Protein 2; Caprylates; Cardiotoxicity; Carnitine; Chick Embryo; Cytoprotection; Environmental Pollutants; Fluorocarbons; Gene Expression Regulation, Developmental; Gene Silencing; Heart; Heart Diseases; Heart Rate; Phosphorylation; PPAR alpha; Recombinant Proteins; Signal Transduction; Smad1 Protein; Ventricular Function, Right; Ventricular Remodeling | 2018 |
T3 treatment does not prevent myocardial dysfunction in chronically diabetic rats.
Topics: Animals; Caprylates; Cytochrome c Group; Diabetes Mellitus, Experimental; Half-Life; Heart Diseases; Heart Rate; Isoproterenol; Male; Oxygen Consumption; Rats; Rats, Inbred Strains; Triiodothyronine | 1988 |